Abstract-Human liver samples from 17 embryos, 5 fetuses, 5 infants and 4 adults were used to investigate human liver cytochrome P-450-dependent 7-alkoxy coumarin 0-dealkylase activities, and their drug-metabolizing activities were compared to those of rat livers. The 0-dealkylase activities in human embryos and fetuses were very low, although detectable, similar to those in fetal rats. Both male and female rats showed a postnatal increase of hepatic 0-dealkylase activities with a maximum at about 30-40 days after birth and then a decline in the activities which was marked in female rats.
Adult female rats showed a marked decrease in the hepatic enzyme activity observed in the 0-depropylation reaction rather than the 0-demethylation and 0-deethylation reactions. During the developmental period of human infants, the 0-demethylase activity, but not 0-depropylase activity, increased gradually. Enzymes in adult human livers metabolize the 0-methyl derivative of 7-hydroxycoumarin in preference to the 0-ethyl and 0-propyl derivatives.
The metabolic activities of human adult enzymes for 7-alkoxycoumarin resembled those in adult female rats and were quite different from those in male rats.
The study demonstrated that caution must be exercised in extrapolating pharmacological results from animal to man in the field of drug metabolism.
The hepatic microsomal cytochrome P 450-dependent monooxygenase system has been demonstrated to play a central role in the metabolism of a wide variety of endogenous and exogenous compounds, including human therapeutic drugs (1). The biochemical and biological properties of this enzyme system have been extensively studied in laboratory animals (2-4).
Many inves tigators indicate the existence of multiple forms of cytochrome P-450 In order supplement the information on humans,
we examined the developmental and senile changes of cytochrome P-450 dependent drug -metabolizing activities in human livers at various prenatal and postnatal stages by employing the 7-alkoxycoumarin 0-dealkylation reaction (19) as a model and compared this data with the corresponding animal obtained using rat liver samples.
Materials and Methods

Human liver samples
A piece (about 50-500 mg wet weight) of human liver (Japanese) was obtained from the two sources described below. The samples were immediately stored at -20°C for several weeks to a few months and subjected to the assay. A separate experiment established that no appreciable decrease of activities of the respective enzymes occurred during the storage.
Prenatal samples at 8 to 33 weeks of gestation (menstrual age): These embryos and fetuses arose mostly from induced abortion conducted legally by dilatation and curettage or induced delivery using a bougie or metreurynter:
all showed no external anomalies. The fetuses at and after 24 weeks were derived from spontaneous abortuses with little postmortem changes.
Postnatal samples at 2 weeks to 67 years of age: During surgical procedures, fresh liver specimens are sometimes obtained for diag nostic reasons.
Surplus tissues were used when they had been examined to be free of suspected disease or anomaly of the liver. Animal liver samples Unless otherwise specified, Jcl Sprague Dawley strain rats were used for the experi ments. In some cases, Sic Wistar strain rats were also used. The animals were kept in an air-conditioned room (25±1 °C, 50-60% humidity) lighted 12 hr a day (8:00-20:00) and maintained on commercial rat chow (CA-1, Japan Clea Co., Tokyo) and water ad libitum. The animals were killed by decapitation and liver samples were obtained.
A piece of liver sample (200-500 mg wet weight) obtained from the left lobe was used for activity determination at the homogenate level in adult rats, while whole lobes were used in fetus and neonate rats. Preparation of enzyme samples Human and rat livers were homogenized in ice-cold 0.25 M sucrose containing 50 mM Tris-HCI buffer (pH 7.4) using a glass Potter Elvehjem type homogenizer with a Teflon pestle. The concentration of the homogenate was adjusted to 20-100 mg wet weight of liver/ml, and then filtered through two layers of coarse gauze to remove undispersed connective tissues. The resulting filtrate was used for the assay. Liver microsomes were prepared as described previously (19) . Determination of drug -metabolizing activity and cytochromes 7-Alkoxycoumarin 0-dealkylase activity in both liver microsomes and homogenates was determined as described previously (19) . Cytochromes P-450 and b5 were detected by difference spectrophotometry using a Shimadzu UV-300 spectrophotometer. Cyto chrome P-450 in microsomes was measured according to the method of Omura and Sato (20) . Cytochrome P-450 in liver homogenate was detected as described previously (21), and its concentration was calculated from the spectrum using the molar extinction difference of 104 mM-1 cm-1 (22) for the absorption difference between the peak position (at about 450 nm) and 490 nm. Cytochrome b5 was determined with the NADH-reduced difference spectrum as described previously (23) . Protein concentration was measured by the method of Lowry et al. (24) using bovine serum albumin as a standard.
Detection of reaction products
For product identification, the incubation mixture for the O-dealkylase assay system was incubated for 15 min at 37°C, and the mixture (1.5 ml) was extracted with 4 ml of ether. A precoated thin-layer plate (silica gel 60 F-254, Merck) was used for the separation of ether-extractable products. The solvent system employed was chloroform methanol (10:1, v/v), and the compounds on the plate were detected using a Black ray® lamp (366 nm). Chemicals NADP, NAD(P)H, glucose-6-phosphate and glucose-6-phosphate dehydrogenase were purchased from the Oriental Yeast Co. (Tokyo), and 7-hydroxycoumarin 0-methyl-, 0-ethyl and 0-propyl-derivatives were syn thesized as described previously (25) . Other chemicals of the purest grade available were obtained commercially and used for the experiments without further purification. with rat and human liver enzymes. Rat liver microsomes prepared from normal Sic-Wistar strain male rats were employed for the determination (System 1). Human liver samples were obtained from a 4-year-old child and used at the homogenate level (System 2). 7 Methoxycoumarin (617 nmoles in 1.5 ml reaction mixture) was incubated with the NADPH-generating system and enzyme samples as described previously (19) . After incubation, the reaction metabolites were analyzed as described in "Methods".
Reference samples of 7-methoxy and 7-hydroxy-coumarin are shown in System 3 and System 4, respectively.
Results
Conversion of 7-methoxycoumarin to 7 hydroxycoumarin by hepatic enzymes: 7 Methoxycoumarin was incubated with liver enzymes obtained from human and rats together with an NADPH -generating system. After 15-min incubation, the ether-extractable compounds in the incubation mixture were separated and analyzed by the TLC technique. As reported previously (19, 25) , the thin-layer chromatogram of the ether-extract showed at least four to five fluorescent bands when liver microsomes prepared from adult rats were employed as the enzyme source (Fig. 1,  system 1). A similar chromatogram was obtained when human liver homogenate was used as the enzyme source (Fig. 1, system 2) . In the reaction system lacking the NADPH generating system, a single fluorescent band was detected on the plate, which showed similar mobility to that of authentic 7 methoxycoumarin.
One of the fluorescent bands on the plate showed mobility and fluorescent color (bluish violet) similar to those of authentic 7-hydroxycoumarin ( Fig.  1) , indicating the conversion of 7-methoxy coumarin to 7-hydroxycoumarin by rat and human liver enzymes. The results suggest that 7-alkoxycoumarin is metabolized oxidatively by human liver enzymes, similar to the case of rat liver enzymes. The drug metabolizing capacity of human liver was then determined by measuring the 7 hydroxycoumarin produced during the in vitro incubation and comparing it with that in rat liver.
Hepatic 7-alkoxycoumarin 0-dealkylase activity in human embryos and fetuses: In the past decade, findings have demonstrated that human fetuses possess a well-developed drug-metabolizing system, albeit usually less active than that of the adult (13, 14, 26) . Thus, the 0-dealkylation activity of 7 alkoxycoumarin was determined using liver samples obtained from human embryos and fetuses. TLC analysis of the ether-extract of the incubation mixture containing human fetus liver homogenate and 7-methoxy coumarin also showed the production of 7 hydroxycoumarin, although the fluorescent intensity of the metabolites was very faint. 7-Alkoxycoumarin underwent metabolism in the human fetal liver even in early gestation, although the 0-dealkylation activity in the individual samples varied markedly (Fig. 2) . As shown in the figure, no difference in the 0-dealkylation activity was observed between embryo and fetus livers.
Hepatic 7-alkoxycoumarin 0-dealkylase activity in human infants and adults: Hepatic 7-alkoxycoumarin 0-dealkylase activity determined for liver samples from human children (2 weeks to 4 years in age) and adults (32-67 years old) are shown in Table 1 . The 0-dealkylation activity in a newborn (2 weeks old) was similar to that of fetuses as shown in Fig. 2 years old, was also determined, and very high activity compared to that of infants was observed. Interestingly, adult liver enzymes showed characteristic drug-metabolizing activities: being highest for the 0-demethylation activity of 7 methoxycoumarin and lowest for the 0 depropylation activity (Table 1) .
Hepatic drug-metabolizing activity in rat fetus and dam: 7-Alkoxycoumarin 0 dealkylase activity in rat fetal livers was studied for comparison with human fetal data. The activity determined in rat fetuses of 17 21 days of gestational age (Table 2 ) was almost the same as that of human fetus livers (Fig. 2) . The highest activity in rat fetuses was observed in the 0-demethylation reaction, and the lowest in the 0-depropylation raction. Lower 0-dealkylation activity in fetuses was observed continuously during the gestational period on Day 17-20, followed by a slight increase just before delivery on Day 21 (Table 2) . On the other hand, highest activities were observed when livers obtained from dams were used for the assay (Table 2) . (Table 1) . Thus, the age-related changes in hepatic 0 dealkylase were observed using rats. The activity in male rats increased nearly linearly to a maximum at 30 to 40 days postpartum, and highest activity was continuously observed until 90 days of age (Fig. 3A) . Postnatal development in the 0-dealkylase activity with a maximum at about 30 days of age was also observed in female rats, followed by a remarkable decrease to the adult level (Fig. 3B) . The characteristic developmental profile of the hepatic drug-metabolizing system in female rats displayed a pronounced 0-depropylation reaction rather than 0 demethylation and 0-deethylation reactions. Characteristic metabolic profiles detected in adult female rats was also observed in dam rats as shown in Table 2 . Hepatic 7 alkoxycoumarin 0-dealkylase activities in human and rat samples determined in this report are summarized in Table 3 .
Age-related alteration in cytochrome P 450 content was also checked in both male and female rats. A rapid postnatal increase in the cytochrome P-450 content was observed until 20-30 days after birth. Thereafter, the level remained constant in female rats, but continued to increase gradually with age in male rats (Fig. 4) . The results indicate that the developmental profile of 7-alkoxy coumarin 0-dealkylase activity is not cor related with that of cytochrome P-450 content in rat livers. Liver protein content in various ages of rats was not so different (data not shown). When 7-alkoxycoumarin 0-dealkylase activity and cytochrome P-450 content in developing rat liver homogenates were then expressed on the protein basis, the profiles were the same as those in Figs. 3 and 4 ; and the O-demethylation, 0-deethylation and 0-depropylation activities in adult rats (50 days old) were 345±14, 351 ±21 and 355±27 nmoles/min/mg protein (n=8), respectively, in the males and 127±11, 11 5±8 and 30±2 nmoles/min/mg protein (n=7), respectively, in the females. In addition, when liver micro somes were prepared from male and female rats of various ages and their O-dealkylase activities and cytochrome P-450 contents were determined, the characteristic age related alterations were similar to those at the homogenate level (data not shown). Micro somal cytochrome b5 content and NAD(P)H cytochrome c reductase activity also showed postnatal increases with maxima at 20-30 days after birth, and almost the same level of high activity or content was observed in adult rats of both sexes (data not shown). 
Discussion
The oxidative O-dealkylation reaction of 7 alkoxycoumarin, probably one of the most widely employed assays, was introduced by Ullrich and Weber (27) . Employing the 0 dealkylation reaction of 7-ethoxycoumarin as a model, Kapitulnik et al. found the drug metabolizing activity in adult human livers to be 100-900 nmoles/g liver/hr (1.7-15 nmoles/min/g liver) in 17-98 year old Caucasians and Blacks (16). The activity found for adult Japanese (9.54-11.90 nmoles/min/g liver), shown in Table 1 , agrees with these values. Recent studies have indicated the useful ness of the 0-dealkylation reaction of 7 alkoxycoumarin for assay and routine de tection of alterations in the cytochrome P 450 species (19, 25, 28) . Our study of hepatic drug-metabolizing activities in human infants and adults indicated that the activities increase gradually with age, and the 0 demethylation activity is the highest in adults and the O-depropylation, the lowest (Table  1) . The results indicate probably that the composition of cytochrome P-450 in child livers changes during the developmental period, and the adult human liver contains a specific form(s) of cytochrome P-450 which preferentially catalyzes the 0-demethylation reaction rather than the O-depropylation reaction.
Although we used only adult women's livers, no sex-linked difference in the drug-metabolizing enzyme activity has been established for human livers (29, 30) , and thus the 0-dealkylase activity reported here probably represents the value for adult Japanese livers. Fig. 4 . Developmental profile of hepatic cytochrome P-450 content in rats. Hepatic cytochrome P-450 content in male (open circle) and female rats (closed circle) was detected using whole liver homogenates. Each value represents the mean and standard error of 4-9 animals.
As described in this paper, the 0-dealkylase activity was detected in human fetal livers, even in embryos. The existence of cyto chrome P-450 in human fetal livers has been reported by many investigators (8) (9) (10) (11) 31) , and thus the 0-dealkylation of 7-alkoxy coumarin may be catalyzed by these hemo proteins. Very few studies have compared fetal hepatic enzyme activities with those of adult livers. Of those which have, some have shown that the human fetal liver has a wide substrate specificity, but an activity of generally less than 10% of that in adult livers (26) . Lower 0-dealkylase activity in fetal livers in both humans and rats (Table 3) is compatible with the previous results.
Sex-related differences in hepatic drug metabolizing activity are well known in adult rats (32) . Recent studies by Kamataki et (36) . We also compared the O-dealkylation activities of 7-alkoxycoumarin in normal rats with those in castrated animals. Although the O-dealkylase activities in female rats were not altered by ovariectomy, the activities in male rat livers depressed markedly by the castration, and testosterone pretreatment of castrated males resulted in an increase in the 0-deal kylation activities of 7-alkoxycoumarin, and estradiol administration decreased the activities (T. Matsubara et al., unpublished results). These results indicate probably that androgen-mediated sex differences exist in the 7-alkoxycoumarin O-dealkylation enzyme system i n adult rats.
When 7-alkoxycoumarin 0-dealkylase activities in adult human livers were com pared with those in adult rats, the most widely used experimental animals, a remark able difference was observed between humans and adult male rats. Interestingly, the activities in human livers were almost the same as those in female rats (Table 3) . Kremer et al. compared human liver drug metabolizing activities of several substrates to those of rats and found some resemblance between the enzyme system of human adults and female rats (30) . Several reports have also indicated that the specific contents of cytochrome P-450 and of the components of the cytochrome P-450-dependent mono oxygenase system in the liver are very similar in rats and humans (9, 37, 38). Although human livers are generally considered to have lower oxidative activities than livers of other species, the 0-dealkylase of 7-alkoxy coumarin in human adult livers is as active as that of rat livers (Table 3) , suggesting different substrate specificity in the human mono oxygenase system from that in rats and the necessity of using appropriate substrates to compare the activities.
To determine the physiological and phar macological significance of the hepatic cytochrome P-450-dependent monooxy genase system, determination; of the enzyme activities in the whole liver homogenate may be the best initial step in routine assays. Employment of subcellular fractions of liver cells is not adequate for this purpose because of the low recovery of subcellular mem branous particles during homogenization and centrifugation (19) . In addition, the sub cellular distribution of the monooxygenase system in fetal liver was demonstrated to be different from that in adults (39) , and the human liver samples obtained were not enough to prepare the microsomal fraction. We thus checked the activity in both human and rat livers at the homogenate level. The assay procedure employed was established to be applicable to the homogenate system (19) . In rat liver samples, we also carried out the activity determination at the microsomal level (data not shown) to check the accuracy of the experiments and found no difference between the two enzyme samples.
Our studies demonstrate that the ex trapolation of pharmacological results from animal to man in the field of drug metabolism should only be made with great caution: the metabolism of some chemicals in human livers is very similar to that in rats as indicated in this report, but that of most others is very different as pointed out in numerous reports. The use of human liver samples is a promising tool for testing the metabolic pathway of new drugs in man. 
